Barry D. Greenberg

Health Technology

Consumer Services

Profile

Barry D.
Greenberg is Director of Pharmacology for Bellus Health, Inc. Previously, he was a Director of Alzheimer Amyloid Research Program for Cephalon, Inc. from 1993 to 1997.
Dr. Greenberg received a PhD from the University of North Carolina and a Master's degree and a Bachelor's degree from Northwestern University.

Former positions of Barry D. Greenberg

Companies	Position	End
Cephalon, Inc. Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA.	Corporate Officer/Principal	1996-12-31
BELLUS HEALTH	Corporate Officer/Principal	-

See the detail of Barry D. Greenberg's experience

Training of Barry D. Greenberg

The University of North Carolina at Charlotte	Doctorate Degree
Northwestern University	Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Barry D. Greenberg's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
BELLUS Health, Inc. BELLUS Health, Inc. Pharmaceuticals: MajorHealth Technology BELLUS Health, Inc. is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of cough hypersensitivity and other hypersensitization disorders. Its product BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch. The company was founded on June 17, 1993 and is headquartered in Laval, Canada.	Health Technology
Cephalon, Inc. Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA.	Health Technology